Individualized and Precision Health Management for Diabetes：Evidence from the Latest Guidelines and Development Prospects in China

doi:10.12114/j.issn.1007-9572.2021.00.158

Abstract

Abstract: The individualized and precision health management level is essentially associated with the preventive and therapeutic results in chronic diseases due to long-term course，complex etiology and multiple complications.Individualized and precision health management for chronic disease has been included in the list of key services of healthcare institutions in developed countries，but in China，there is a lack of sufficient relevant theories，and a complete practice system as well as mature practice skills.Based on the reviewing of the latest guidelines for diabetes，we analyzed the development of individualized and precision health management for diabetes in foreign countries and China，with a view to providing information for promoting its development in China.

Key words: Chronic disease, Diabetes mellitus, Guidebooks, Individualized medicine, Disease management, Decision making

摘要： 慢性病发病周期长、病因复杂、合并症多，防治效果常取决于个体化、精细化的健康管理服务。在发达国家，慢性病个体化、精细化管理已被列入医疗机构重点服务清单，而我国尚缺乏慢性病个体化、精细化健康管理服务的理论积累和实践，且缺少完备的体系和成熟的技术。本文以糖尿病为例，结合国内外最新指南分析了慢性病个体化、精细化健康管理服务发展情况及我国发展现状，以期为推动我国个体化、精细化健康管理服务发展提供参考。

关键词: 慢性病, 糖尿病, 指南, 个体化医学, 疾病管理, 决策

ZENG Zhitong,WANG Zhaoxin,WANG Hui, et al. Individualized and Precision Health Management for Diabetes：Evidence from the Latest Guidelines and Development Prospects in China　[J]. Chinese General Practice, 2021, 24(9): 1037-1043. DOI: 10.12114/j.issn.1007-9572.2021.00.158.
曾志童,王朝昕,王慧等. 基于国内外最新指南的慢性病个体化、精细化健康管理服务分析及我国发展前景——以糖尿病为例[J]. 中国全科医学, 2021, 24(9): 1037-1043. DOI: 10.12114/j.issn.1007-9572.2021.00.158.

References

［1］American Diabetes Association.1.Improving Care and Promoting Health in Populations：Standards of Medical Care in Diabetes-2020［J］．Diabetes Care，2020，43（Suppl 1）：S7-13．DOI：10.2337/dc20-S001.
［2］American Diabetes Association.2.Classification and Diagnosis of Diabetes：Standards of Medical Care in Diabetes-2020［J］．Diabetes Care，2020，43（Suppl 1）：S14-31．DOI：10.2337/dc20-S002.
［3］American Diabetes Association.3.Prevention or Delay of Type 2 Diabetes:Standards of Medical Care in Diabetes-2020 ［J］．Diabetes Care，2020，43（Supplement 1）:S32-36．DOI：10.2337/dc20-S003.
［4］American Diabetes Association.4.Comprehensive Medical Evaluation and Assessment of Comorbidities：Standards of Medical Care in Diabetes-2020［J］．Diabetes Care，2020，43（Suppl 1）：S37-47．DOI：10.2337/dc20-S004.
［5］American Diabetes Association.5.Facilitating Behavior Change and Well-being to Improve Health Outcomes：Standards of Medical Care in Diabetes-2020［J］．Diabetes Care，2020，43（Suppl 1）：S48-65．DOI：10.2337/dc20-S005.
［6］American Diabetes Association.6.Glycemic Targets：Standards of Medical Care in Diabetes-2020［J］．Diabetes Care，2020，43（Suppl 1）：S66-76．DOI：10.2337/dc20-S006.
［7］American Diabetes Association.8.Obesity Management for the Treatment of Type 2 Diabetes：Standards of Medical Care in Diabetes-2020［J］．Diabetes Care，2020，43（Suppl 1）：S89-97．DOI：10.2337/dc20-S008.
［8］The Royal Australian College of General Practitioners.Guidelines for preventive activities in general practice［M］．9th ed.East Melbourne，Vic：RACGP，2018.
［9］The Royal Australian College of General Practitioners.Putting prevention into practice：guidelines for the implementation of prevention in the general practice setting［M］．East Melbourne，Vic：RACGP，2018.
［10］The Royal Australian College of General Practitioners.Standards for general practices［M］．5th ed.East Melbourne，Vic：RACGP，2019.
［11］The Royal Australian College of General Practitioners.General practice management of type 2 diabetes：2016—18［M］．East Melbourne，Vic：RACGP，2018.
［12］中华医学会糖尿病学分会.中国2型糖尿病防治指南（2017年版）［J］．中国实用内科杂志，2018，38（4）：292-344．DOI：10.19538/j.nk2018040108.
Chinese Diabetes Society.Guidelines for the prevention and control of type 2 diabetes in China（2017 Edition）［J］．Chinese Journal of Practical Internal Medicine，2018，38（4）：292-344．DOI：10.3760/cma.j.issn.1674-5809.2018.01.003.
［13］中华医学会糖尿病学分会，国家基层糖尿病防治管理办公室.国家基层糖尿病防治管理手册（2019）［J］．中华内科杂志，2019，58（10）：713-735．DOI：10.3760/cma.j.issn.0578-1426.2019.10.003.
Chinese Diabetes Society，National Office for Primary Diabetes Care.National handbook for the prevention and control of diabetes in primary care（2019）［J］．Chinese Journal of Internal Medicine，2019，58（10）：713-735．DOI：10.3760/cma.j.issn.0578-1426.2019.10.003.
［14］中华医学会糖尿病学分会.中国糖尿病护理及教育指南［M/OL］．2009［2020-09-15］．https：//wenku.baidu.com/view/55428fe4cd7931b765ce0508763231126fdb7761.html.
［15］中华医学会糖尿病学分会.中国糖尿病运动治疗指南［M］．北京：中华医学电子音像出版社，2012.
［16］中华医学会糖尿病学分会，中国医师协会营养医师专业委员会.中国糖尿病医学营养治疗指南（2013）［J］．中华糖尿病杂志，2015，7（2）：73-88．DOI：10.3760/cma.j.issn.1674-5809.2015.02.004.
［17］李立明，吕筠.中国慢性病研究及防治实践的历史与现状［J］．中华流行病学杂志，2011，32（8）：741-745．DOI：10.3760/cma.j.issn.0254-6450.2011.08.001.
LI L M，LYU J.History and current status of research and practices in the prevention and treatment of chronic diseases in China［J］．Chinese Journal of Epidemiology，2011，32（8）：741-745．DOI：10.3760/cma.j.issn.0254-6450.2011.08.001.
［18］蒋品，唐海沁，何伟，等．国内外慢性病基层临床指南现状分析［J］．中国循证心血管医学杂志，2015，7（4）：439-443．DOI：10.3969/j.1674-4055.2015.04.03.
JIANG P，TANG H Q，HE W，et al．Current status of grassroots clinical guidelines of chronic diseases at home and abroad［J］．Chinese Journal of Evidence-Based Cardiovascular Medicine，2015，7（4）：439-443．DOI：10.3969/j.1674-4055.2015.04.03
［19］秦维章.中国高血压防治指南在社区慢性病健康管理中的应用现状研究［D］．南京：东南大学，2016．DOI：10.7666/d.Y3089839.
［20］许培海.我国区域卫生信息平台建设现状及趋势研究［J］．中国数字医学，2016，11（5）：23-26．DOI：10.3969/j.issn.1673-7571.2016.05.007.
XU P H.Status and trend of regional health information platform construction in China［J］．China Digital Medicine，2016，11（5）：23-26．DOI：10.3969/j.issn.1673-7571.2016.05.007.
［21］窦伟洁，甄天民，赵芳，等．基于电子健康档案的慢病防控区域信息平台探索［J］．医学信息学杂志，2014，35（7）：12-16．DOI：10.3969/j.issn.1673-6036.2014.07.003.
DOU W J，ZHEN T M，ZHAO F，et al．Exploration on chronic disease prevention and control regional information platform based on electronic health records［J］．Journal of Medical Intelligence，2014，35（7）：12-16．DOI：10.3969/j.issn.1673-6036.2014.07.003.
［22］CHEN Z，LEE L，CHEN J，et al．Cohort profile：the Kadoorie Study of Chronic Disease in China（KSCDC）［J］．Int J Epidemiol，2005，34（6）：1243-1249．DOI：10.1093/ije/dyi174.
［23］CHEN Z，CHEN J，COLLINS R，et al．China Kadoorie Biobank of 0.5 million people：survey methods，baseline characteristics and long-term follow-up［J］．Int J Epidemiol，2011，40（6）：1652-1666．DOI：10.1093/ije/dyr120.
［24］PANG Y，KARTSONAKI C，GUO Y，et al．Diabetes，plasma glucose and incidence of colorectal cancer in Chinese adults：a prospective study of 0.5 million people［J］．J Epidemiol Community Health，2018，72（10）：919-925．DOI：10.1136/jech-2018-210651.
［25］BRAGG F，LI L，YANG L，et al．Risks and population burden of cardiovascular diseases associated with diabetes in China：a prospective study of 0.5 million adults［J］．PLoS Med，2016，13（7）：e1002026．DOI：10.1371/journal.pmed.1002026.
［26］BENNETT D A，DU H，BRAGG F，et al．Physical activity，sedentary leisure-time and risk of incident type 2 diabetes：a prospective study of 512 000 Chinese adults［J］．BMJ Open Diabetes Res Care，2019，7（1）：e000835．DOI：10.1136/bmjdrc-2019-000835.
［27］PANG Y，KARTSONAKI C，TURNBULL I，et al．Diabetes，plasma glucose，and incidence of fatty liver，cirrhosis，and liver cancer：a prospective study of 0.5 million people［J］．Hepatology，2018，68（4）：1308-1318．DOI：10.1002/hep.30083.
［28］BRAGG F，HOLMES M V，IONA A，et al．Association between diabetes and cause-specific mortality in rural and urban areas of China［J］．JAMA，2017，317（3）：280-289．DOI：10.1001/jama.2016.19720.
［29］LI H，LV J，YU C，et al．The association between age of alcohol onset with type 2 diabetes：a 0.5 million cohort study in China［J］．Am J Epidemiol，2020，kwaa119．DOI：10.1093/aje/kwaa119．［Online ahead of print］．
［30］CHEN Y，LI L，ZHANG Q，et al．Use of drug treatment for secondary prevention of cardiovascular disease in urban and rural communities of China：China Kadoorie Biobank Study of 0.5 million people［J］．Int J Cardiol，2014，172（1）：88-95．DOI：10.1016/j.ijcard.2013.12.065.
［31］PANG Y，KARTSONAKI C，GUO Y，et al．Socioeconomic status in relation to risks of major gastrointestinal cancers in Chinese adults：a prospective study of 0.5 million people［J］．Cancer Epidemiol Biomarkers Prev，2020，29（4）：823-831．DOI：10.1158/1055-9965.EPI-19-0585.
［32］PANG Y，HOLMES M V，GUO Y，et al．Smoking，alcohol，and diet in relation to risk of pancreatic cancer in China：a prospective study of 0.5 million people［J］．Cancer Med，2018，7（1）：229-239．DOI：10.1002/cam4.1261.
［33］PANG Y，KARTSONAKI C，GUO Y，et al．Central adiposity in relation to risk of liver cancer in Chinese adults：a prospective study of 0.5 million people［J］．Int J Cancer，2019，145（5）：1245-1253．DOI：10.1002/ijc.32148.
［34］PANG Y，KARTSONAKI C，GUO Y，et al．Adiposity and risks of colorectal and small intestine cancer in Chinese adults：a prospective study of 0.5 million people［J］．Br J Cancer，2018，119（2）：248-250．DOI：10.1038/s41416-018-0124-8.
［35］SI J，YU C，GUO Y，et al．Chronic hepatitis B virus infection and total and cause-specific mortality：a prospective cohort study of 0.5 million people［J］．BMJ Open，2019，9（4）：e027696．DOI：10.1136/bmjopen-2018-027696.
［36］WANG M，GONG W W，HU R Y，et al．Associations between stressful life events and diabetes：Findings from the China Kadoorie Biobank study of 500，000 adults［J］．J Diabetes Investig，2019，10（5）：1215-1222．DOI：10.1111/jdi.13028.
［37］MILLWOOD I Y，LI L，SMITH M，et al．Alcohol consumption in 0.5 million people from 10 diverse regions of China：prevalence，patterns and socio-demographic and health-related correlates［J］．Int J Epidemiol，2013，42（3）：816-827．DOI：10.1093/ije/dyt078.
［38］LI H，KHOR C C，FAN J，et al．Genetic risk，adherence to a healthy lifestyle，and type 2 diabetes risk among 550，000 Chinese adults：results from 2 independent Asian cohorts［J］．Am J Clin Nutr，2020，111（3）：698-707．DOI：10.1093/ajcn/nqz310.
［39］DU H，LI L，BENNETT D，et al．Fresh fruit consumption in relation to incident diabetes and diabetic vascular complications：a 7-y prospective study of 0.5 million Chinese adults［J］．PLoS Med，2017，14（4）：e1002279．DOI：10.1371/journal.pmed.1002279.
［40］吕欣航，雷行云，皮宇奇，等．我国基层卫生信息化建设与发展的SWOT分析［J］．实用心脑肺血管病杂志，2019，27（3）：10-13．DOI：10.3969/j.issn.1008-5971.2019.03.002.
LYU X H，LEI X Y，PI Y Q，et al．SWOT analysis on the construction and development of grass-roots health informatization in china ［J］．Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease，2019，27（3）：10-13．DOI：10.3969/j.issn.1008-5971.2019.03.002.
［41］李菁.加强社区卫生服务信息化建设已刻不容缓［J］．智慧健康，2018，4（1）：5-7．DOI：10.19335/j.cnki.2096-1219.2018.01.03.
LI J.Urgent to stengthen the informatization constraction of community health services ［J］．Smart Healthcare，2018，4（1）：5-7．DOI：10.19335/j.cnki.2096-1219.2018.01.03.
［42］乔静，雷行云，陈庆锟，等．我国基层卫生信息化评价研究综述［J］．医学信息学杂志，2017，38（9）：51-55．DOI：10.3969/j.issn.1673-6036.2017.09.011.
QIAO J，LEI X Y，CHEN Q，et al．Review of research on grass-roots health informatization evaluation in China［J］．Journal of Medical Informatics，2017，38（9）：51-55．DOI：10.3969/j.issn.1673-6036.2017.09.011.
［43］杜小雅，何炜，陈育庆，等．信息化平台下社区卫生服务能力提升路径研究：基于价值网络视角［J］．中国卫生事业管理，2019，36（8）：569-572，582.
DU X Y，HE W，CHEN Y Q，et al．Research on the improvement path of community health service capacity under the information platform：from the perspective of Value Network［J］．Chinese Health Service Management，2019，36（8）：569-572，582.
［44］代谢中心学术委员会，代谢中心专家顾问委员会，代谢中心理事会，等．国家标准化代谢性疾病管理中心建设规范及管理指南［J］．中华内分泌代谢杂志，2019，35（11）：907-926．DOI：10.3760/cma.j.issn.1000-6699.2019.11.001.
［45］林嘉敏，肖柳红，张舒婷，等．基于代谢性疾病管理中心平台健康教育在出院后2型糖尿病患者中的应用［J］．现代临床护理，2019，18（2）：57-62．DOI：10.3969/j.issn.1671-8283.2019.02.012.
LIN J M，XIAO L H，ZHANG S T，et al．Application of health education based on metabolic disease management information platform in patients with type 2 diabetes after discharge［J］．Modern Clinical Nursing，2019，18（2）：57-62．DOI：10.3969/j.issn.1671-8283.2019.02.012.

[1]	WANG Zhe, DONG Zhihao, ZHENG Hao, KONG Wencheng, ZHANG Yukuan, ZHANG Qiuyue, HAN Jing. Construction of Optimized Treatment Plan of Acupuncture for Migraine Based on Entropy Weight-TOPSIS Method [J]. Chinese General Practice, 2023, 26(34): 4336-4342.
[2]	LI Dianjiang, PAN Enchun, SUN Zhongming, WEN Jinbo, WANG Miaomiao, WU Ming, SHEN Chong. The Current Status and Influencing Factors of Clinical Inertia in Type 2 Diabetes Patients in Community [J]. Chinese General Practice, 2023, 26(34): 4296-4301.
[3]	LIN Kai, YAO Mi, CHEN Zhang, JI Xinxin, LIN Runqi, CHEN Yongsong, Sim MOIRA. Conceptual Framework and Responding Approach of Treatment Burden of Type 2 Diabetes: a Video Recording-based Analysis [J]. Chinese General Practice, 2023, 26(34): 4302-4307.
[4]	YANG Hui, HU Ruwei, LIU Ruqing, LU Junfeng, WU Jinglan. Relationship between Community Health Service Experience and Glycemic Control Outcomes in Patients with Diabetes Mellitus [J]. Chinese General Practice, 2023, 26(34): 4290-4295.
[5]	YU Xinyan, ZHAO Jun, ZHAO Xiaoye, JIANG Qingru, CHEN Yatian, WANG Yan, ZHANG Haicheng. Application of Mobile Smart Healthcare in the Prevention and Control of Cardiovascular Diseases in Elderly Patients with Chronic Diseases in Primary Care [J]. Chinese General Practice, 2023, 26(33): 4167-4172.
[6]	ZHOU Yuyu, GAO Chuan, CUI Puan, WANG Yaping, HE Zhong. Influencing Factors of Shared Decision Making between Doctors and Patients in Menopausal Hormone Therapy in Patients with Menopausal Syndrome [J]. Chinese General Practice, 2023, 26(33): 4181-4186.
[7]	ZHANG Juan, LI Haifen, LI Xiaoman, YAO Miao, MA Huizhen, MA Qiang. Construction of Recurrence Risk Prediction Model for Diabetic Foot Ulcer on the Basis of Logistic Regression, Support Vector Machine and BP Neural Network Model [J]. Chinese General Practice, 2023, 26(32): 4013-4019.
[8]	CHENG Jingwei, QIAO Junjun, YIN Zhen, HU Junpeng, WANG Qinghe, LIU Yangqing, WANG Yanfang. Interpretation of ISPAD Clinical Practice Consensus Guidelines 2022: Exercise in Children and Adolescents with Diabetes [J]. Chinese General Practice, 2023, 26(30): 3719-3724.
[9]	PAN Ye, LIU Zhihui, HU Qianqian, WANG Liuyi. Patterns of Coexistence of Multiple Chronic Conditions among Chinese Elderly [J]. Chinese General Practice, 2023, 26(29): 3608-3615.
[10]	WANG Xiaoran, ZHANG Dan. Influence of Multimorbidity on Anxiety Symptoms among Chinese Elderly People: a Propensity Score-matched Study [J]. Chinese General Practice, 2023, 26(29): 3622-3627.
[11]	ZHOU Xiaoqi, LIU Xinhui, ZHANG Wei, LI Changfeng, YAN Yaqiong. Association of Alanine Transaminase and Aspartate Aminotransferase/Alanine Transaminase Ratio with Type 2 Diabetes and Metabolic Syndrome in the Elderly [J]. Chinese General Practice, 2023, 26(29): 3645-3649.
[12]	ZHAO Xiaohua, DU Lin, GAO Shengnan, JIANG Ziyun. Multiple Deep Muscle Abscesses in Type 2 Diabetes in the Elderly: Report of One Case and Literature Review [J]. Chinese General Practice, 2023, 26(29): 3715-3718.
[13]	SUN Mengjie, LIU Lamei, WANG Jia'nan, WANG Peng, ZHANG Zhenxiang. A Meta-synthesis of Qualitative Studies on the Real Experiences and Care Experience during Hospital-to-home Transition for Elderly Patients with Chronic Diseases [J]. Chinese General Practice, 2023, 26(28): 3565-3572.
[14]	GAO Yanli, WANG Hongjun, SUN Fei, JI Xiangqin, Changizi Roohollah. Exploration of Chronic Disease Management Model in Secondary Private General Hospital [J]. Chinese General Practice, 2023, 26(28): 3585-3590.
[15]	GUO Jia, SUN Huajun, CHEN Ying, ZHANG Jiawen, ZHANG Yaxin, MA Ying, DU Yue. Construction of On-site Evaluation Index System for Integration of Medical and Preventive Services for Chronic Diseases in Primary Health Care Institutions [J]. Chinese General Practice, 2023, 26(28): 3489-3495.